Reassessment of cardiotonic drugs in heart failure

doi:10.3969/j.issn.1004-583X.2017.03.002

Abstract

Abstract: Cardiotonic drugs are divided into two categories of digitalis and nondigitalis drugs. Cardiotonic drugs have been used as the first choice drugs in the treatment of heart failure for more than 200 years. However， their evidence for longterm prognosis is not sufficient. Many clinical trials and post hoc analysis of the longterm efficacy of cardiotonic drugs to evaluate， the results are controversial. Due to the lack of evidencebased support， cardiotonic drugs have been used as the final choice in the treatment of heart failure.

Key words: cardiotonic drugs, digoxin, digitalis, heart failure, guidebooks

Zhao Guoyan，Sun Yuemin. Reassessment of cardiotonic drugs in heart failure[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2017.03.002.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2017.03.002

https://huicui.hebmu.edu.cn/EN/Y2017/V32/I3/189

[1]	Duan Fang, Cui Wei. Application principles of vasodilators in the treatment of acute heart failure [J]. Clinical Focus, 2023, 38(9): 773-778.
[2]	Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian. Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation [J]. Clinical Focus, 2023, 38(4): 308-314.
[3]	Li Nana, Jiang Shan. Predictive values of serum homocysteine, cystatin C and high sensitive C-reactive protein levels on heart failure after percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction [J]. Clinical Focus, 2023, 38(2): 121-125.
[4]	Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong. Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score [J]. Clinical Focus, 2023, 38(2): 117-120.
[5]	Zhang Jingshui, Xu Yanan, Wang Jun, Yang Yi, Jiang Haibing, Tang Long, Wang Xianping, Shao Mingliang. Clinical characteristics and long-term prognosis of initial patients with new onset different type of heart failure combined atrial fibrillation [J]. Clinical Focus, 2022, 37(6): 504-509.
[6]	Li Heng, Li Yonghui, Sun Xiaoqiang, Wang Lin, He Feng. Efficacy and safety of anticoagulant therapy for patients with heart failure in sinus rhythm [J]. Clinical Focus, 2022, 37(5): 406-411.
[7]	Wang Runqing, Wang Qian, Liao Jianxiong. A network meta-analysis of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes [J]. Clinical Focus, 2022, 37(12): 1061-1073.
[8]	Zuo Xiuxiu, Hou Tianhua, Wang Hongxiang. Effect of subclinical hypothyroidism on prognosis of patients with chronic systolic heart failure: A meta-analysis [J]. Clinical Focus, 2022, 37(10): 905-911.
[9]	Luo Fanglin, Guan Suying, Wu Guoxiang. Clinical effect of sacubitril-valsartan combined with activin on acute left heart failure [J]. Clinical Focus, 2021, 36(9): 782-785.
[10]	Ma Fei, Fang Xuehua, Gao Dequan, Zhang Wei. Efficacy of Metoprolol Succinate combined with Trimetazidine on coronary heart disease and heart failure: a meta-analysis [J]. Clinical Focus, 2021, 36(6): 491-499.
[11]	Xu Dongrui, Zhao Qinhui, Liu Tongxiang. Clinical effect of sacubitril/valsartan for heart failure with mid-range ejection fraction in left ventricle [J]. Clinical Focus, 2021, 36(5): 416-420.
[12]	Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang. Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation [J]. Clinical Focus, 2021, 36(5): 412-415.
[13]	Bai Lian, Guo Peng, Luan Bo, Bai Hao, Jiang Shan. Correlation between serum free fatty acid and cardiac function in patients with acute heart failure [J]. Clinical Focus, 2021, 36(3): 208-211.
[14]	Li Heng, Li Yonghui, Wang Lin, He Feng. Correlation analysis of nutritional status and prognosis for heart failure in elderly women [J]. Clinical Focus, 2021, 36(12): 1079-1082.
[15]	Zhang Yiran. A systematic review of hypoparathyroid cardiomyopathy [J]. Clinical Focus, 2020, 35(9): 783-787.

Reassessment of cardiotonic drugs in heart failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments